NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,787,430 | -13.9% | 560,167 | -5.3% | 0.04% | -4.3% |
| Q2 2023 | $28,793,159 | -8.8% | 591,721 | +4.0% | 0.05% | -11.5% |
| Q1 2023 | $31,581,717 | +28932.7% | 568,835 | +20905.7% | 0.05% | – |
| Q4 2022 | $108,780 | -98.1% | 2,708 | -97.9% | 0.00% | -100.0% |
| Q3 2022 | $5,746,000 | +5123.6% | 131,149 | +4732.3% | 0.01% | – |
| Q1 2022 | $110,000 | -100.0% | 2,714 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $379,131,000 | – | 4,059,674 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |